NCT02125266View on ClinicalTrials.gov

Safety and Preliminary Efficacy Study of V404 PDS in Uveitis

PHASE1/PHASE2TerminatedINTERVENTIONAL

Enrollment

7

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

March 31, 2015

Conditions

Uveitis, PosteriorUveitis, Intermediate

Interventions

DRUG

V404

Sustained Release

Trial Locations (5)

Unknown

Golden

Atlanta

Omaha

Cleveland

Arlington

Sponsors

Lead Sponsor

Forsight Vision4

All Listed Sponsors

lead

Forsight Vision4

INDUSTRY